TARO PHARMACEUTICAL INDUS (TARO) Stock Earnings & Estimates
USA - NYSE:TARO - IL0010827181 - Common Stock
42.97 USD
0 (0%)
42.97 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 561.3M 2.24% | 573M 2.08% | 629.182M 9.80% | |
| EBITDA YoY % growth | 150.9M -10.60% | 49.8M -67.00% | 52.602M 5.63% | |
| EBIT YoY % growth | 125M -13.85% | 17.7M -85.84% | 21.508M 21.51% | |
| Operating Margin | 22.27% | 3.09% | 3.42% | |
| EPS YoY % growth | 3.18 131.45% | 1.03 -67.61% | 1.72 66.99% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 0.40 -25.93% | 0.32 | 0.08 | 26.50% |
| Q3 2024 Q2Q % growth | 0.54 184.21% | 0.31 | 0.23 | 76.47% |
| Q2 2024 Q2Q % growth | 0.38 642.86% | 0.18 | 0.20 | 106.97% |
| Q1 2024 Q2Q % growth | 0.40 8.11% | 0.32 | 0.08 | 26.50% |
| Q4 2023 Q2Q % growth | 0.54 -26.03% | 0.31 | 0.23 | 76.47% |
| Q3 2023 Q2Q % growth | 0.19 -72.86% | 0.89 | -0.70 | -78.59% |
| Q2 2023 Q2Q % growth | -0.07 -110.61% | 0.86 | -0.93 | -108.17% |
| Q1 2023 Q2Q % growth | 0.37 -66.06% | 0.87 | -0.50 | -57.32% |
| Q4 2022 Q2Q % growth | 0.73 193.59% | 0.90 | -0.17 | -18.67% |
| Q3 2022 Q2Q % growth | 0.70 -18.60% | 0.93 | -0.23 | -24.59% |
| Q2 2022 Q2Q % growth | 0.66 -44.07% | 1.04 | -0.38 | -36.56% |
| Q1 2022 Q2Q % growth | 1.09 109.59% | 0.86 | 0.23 | 27.22% |
| Q4 2021 Q2Q % growth | -0.78 -154.93% | 0.94 | -1.72 | -183.12% |
| Q3 2021 Q2Q % growth | 0.86 -51.14% | 1.03 | -0.17 | -16.52% |
| Q2 2021 Q2Q % growth | 1.18 -19.18% | 0.79 | 0.39 | 50.24% |
| Q1 2021 Q2Q % growth | -11.37 -761.05% | 1.18 | -12.55 | -1,060.95% |
| Q4 2020 Q2Q % growth | 1.42 -6.58% | 1.56 | -0.14 | -9.01% |
| Q3 2020 Q2Q % growth | 1.76 -26.67% | 1.57 | 0.19 | 12.04% |
| Q2 2020 Q2Q % growth | 1.46 -3.95% | 1.75 | -0.29 | -16.78% |
| Q1 2020 Q2Q % growth | 1.72 0.58% | 2.00 | -0.28 | -13.97% |
| Q4 2019 Q2Q % growth | 1.52 | 2.31 | -0.79 | -34.06% |
| Q3 2019 Q2Q % growth | 2.40 | 1.99 | 0.41 | 20.66% |
| Q2 2019 Q2Q % growth | 1.52 | 2.00 | -0.48 | -23.97% |
| Q1 2019 Q2Q % growth | 1.71 | 2.38 | -0.67 | -28.05% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 164.941M 4.96% | 159.18M | 5.761M | 3.62% |
| Q3 2024 Q2Q % growth | 157.145M 12.89% | 158.01M | -865K | -0.55% |
| Q2 2024 Q2Q % growth | 148.202M 13.56% | 164.36M | -16.158M | -9.83% |
| Q1 2024 Q2Q % growth | 164.941M 5.26% | 159.18M | 5.761M | 3.62% |
| Q4 2023 Q2Q % growth | 157.145M 9.66% | 158.01M | -865K | -0.55% |
| Q3 2023 Q2Q % growth | 139.2M 0.14% | 166.38M | -27.18M | -16.34% |
| Q2 2023 Q2Q % growth | 130.5M -1.14% | 164.24M | -33.74M | -20.54% |
| Q1 2023 Q2Q % growth | 156.7M 6.53% | 152.87M | 3.83M | 2.51% |
| Q4 2022 Q2Q % growth | 143.3M -3.37% | 149.95M | -6.65M | -4.43% |
| Q3 2022 Q2Q % growth | 139M -0.79% | 145.07M | -6.07M | -4.18% |
| Q2 2022 Q2Q % growth | 132M -7.56% | 156.29M | -24.29M | -15.54% |
| Q1 2022 Q2Q % growth | 147.1M 25.09% | 139.97M | 7.13M | 5.09% |
| Q4 2021 Q2Q % growth | 148.3M -15.21% | 150.27M | -1.97M | -1.31% |
| Q3 2021 Q2Q % growth | 140.1M -5.15% | 155.69M | -15.59M | -10.01% |
| Q2 2021 Q2Q % growth | 142.8M -11.25% | 127.85M | 14.95M | 11.69% |
| Q1 2021 Q2Q % growth | 117.6M -27.09% | 161.52M | -43.92M | -27.19% |
| Q4 2020 Q2Q % growth | 174.9M -2.78% | 171.61M | 3.29M | 1.92% |
| Q3 2020 Q2Q % growth | 147.7M -16.27% | 175.45M | -27.75M | -15.82% |
| Q2 2020 Q2Q % growth | 160.9M 1.19% | 171.93M | -11.03M | -6.42% |
| Q1 2020 Q2Q % growth | 161.3M 4.33% | 173.2M | -11.9M | -6.87% |
| Q4 2019 Q2Q % growth | 179.9M | 193.72M | -13.82M | -7.13% |
| Q3 2019 Q2Q % growth | 176.4M | 178.2M | -1.8M | -1.01% |
| Q2 2019 Q2Q % growth | 159M | 170.76M | -11.76M | -6.89% |
| Q1 2019 Q2Q % growth | 154.6M | 183.13M | -28.53M | -15.58% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |